TAILIEUCHUNG - A comparative study of screening of hepatitis B by two different immunochromatographic methods among patients attending a Tertiary care hospital

Hepatitis B is one of the major Global health problems affecting both developing and developed countries. Hepatitis B is caused by Hepatitis B virus which spreads parentally through blood and sexual contact. There are many markers which gives information regarding stages of hepatitis B viral infection. The HBsAg is used for detection and screening of HBV infection. Aim: The study was carried to compare different parameters viz. sensitivity, specificity, positive and negative predictive values of two immunochromatographic Rapid tests with ELISA for HBsAg. Study Design. The study was conducted in Department of Microbiology at SKIMS-MC Hospital for a period of one year. Result: Out of total of 6701 blood samples screened, 19 were positive by ELISA, 17 were positive by Test A (HepaTM Card) and 16 were positive by Test B (Alere Trueline). The sensitivity, specificity, negative and positive predictive value of test A were , 100%, and 100%. The sensitivity, specificity, negative and positive predictive value of test B were , 100%, and 100% respectively against ELISA. The Rapid tests (ICT) are not comparable to ELISA in terms of sensitivity but can be used for screening of Hepatitis B in developing countries where resources are limited as rapid tests are cost effective and easy to perform. | A comparative study of screening of hepatitis B by two different immunochromatographic methods among patients attending a Tertiary care hospital

• Y khoa - Dược
• Hepatitis B
• Rapid tests
• Comparative study of screening
• hepatitis B
• Different immunochromatographic methods
• Patients attending
• Transmission of hepatitis B
• Natural history
• Laboratory diagnosis of hepatitis B
• Screening of chronic hepatitis B
• Long term monitoring
• Chronic hepatitis B
• Hepatitis B vaccination
• Management of acute viral hepatitis
• Acute hepatitis A
• Acute hepatitis B
• Acute hepatitis C
• Acute hepatitis E
• Seroprevalence of hepatitis B virus
• Hepatitis B virus
• Multitransfused patients
• Special reference
• Occult hepatitis B virus infection
• Comprehensive textbook
• Hepatitis B management
• Antivirals against hepatitis B virus
• Acute liver failure
• Immunosupressive therapies
• ICTC at tertiary care centre
• Tertiary care centre
• Seroprevalence of hepatitis B
• Hepatitis B in HIV positive cases
• Antibody to hepatitis B surface antigen
• Chemi luminescence immuno assay
• Health care workers
• Non responders
• Hepatitis B infection
• Hepatitis B surface antigen
• Hepatitis C antibody
• Pre operative patients
• Tertiary care hospital
• Antenatal women
• Hepatitis C
• New born
• Hepatitis C and syphilis
• Hepatitis C viral infections
• Multiple blood transfusions
• Patients undergoing multiple blood
• BMC Pediatrics
• Hepatitis B surface antibody
• Hepatitis C virus
• HBV antigen
• Dual infection
• Miso extracts
• Rice koji
• Hepatitis A virus
• Blood transfusion
• Thalassemic patients
• Human hepatitis B virus
• Nicotinamide adenine dinucleotide
• Hepatitis B virus X protein
• Transcribe pre genomic RNA
• HBV mediated HCC
• Mother to child transmission
• Antiviral therapy
• Nucleos(t)ide analogues
• Immunochromato graphic assays
• Hepatitis B immunoglobulin
• Meta analysis
• Serological and molecular diagnosis
• Comparative assessment
• Molecular diagnosis
• Chronic infection
• Global public health problem
• Complications like cirrhosis
• BMC Cancer
• Hepatitis B virus screening
• Planned rituximab therapy
• HBV risk factors
• HBV infection
• Risk factors
• HBsAg detection
• Anti HBs titre
• Chronic hepatitis B virus
• Transaminase enzyme
• Serum HBsAg level
• Mild constitutional symptoms
• Hepatocellular carcinoma
• Tenofovir disoproxil fumarate